A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia.
Details
Serval ID
serval:BIB_2B97F304D22F
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Institution
Title
A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia.
Journal
European Journal of Pediatrics
ISSN
0340-6199 (Print)
ISSN-L
0340-6199
Publication state
Published
Issued date
1995
Volume
154
Number
3
Pages
215-219
Language
english
Notes
Publication types: Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't Publication Status: ppublish
Abstract
Achondroplasia, the most common form of chondrodysplasia, has been associated with mutations in the gene of the fibroblast growth factor receptor-3 (FGFR-3) on chromosome 4p. All 39 achondroplasia alleles studied so far carried point mutations which caused the same amino acid exchange, a substitution of glycine by arginine at position 380 (G380R) in the transmembrane domain of the receptor. We report on a newborn with achondroplasia who does not carry a G380R mutation but has a mutation causing substitution of a nearby glycine with a cysteine (G375C). This observation indicates allelic heterogeneity and confirms the role of mutations in the transmembrane domain of FGFR-3 in the pathogenesis of achondroplasia.
Keywords
Achondroplasia/genetics, Achondroplasia/radiography, Amino Acid Sequence, Base Sequence, Cell Membrane/pathology, Chromosomes, Human, Pair 4, Cysteine, Glycine, Humans, Infant, Newborn, Male, Molecular Sequence Data, Phenotype, Point Mutation, Polymerase Chain Reaction, Receptors, Fibroblast Growth Factor/genetics, Receptors, Fibroblast Growth Factor/ultrastructure
Pubmed
Create date
14/03/2011 16:14
Last modification date
20/08/2019 13:10
Usage data
